OR13A1: A GPCR Involved in Olfactory System Regulation (G79290)
OR13A1: A GPCR Involved in Olfactory System Regulation
OR13A1, also known as olfactory receptor OR10-3, is a protein that is expressed in the olfactory system of the human body. It is a member of the superfamily of G protein-coupled receptors (GPCRs), which are a family of transmembrane proteins that play an important role in cellular signaling. GPCRs are characterized by the presence of a catalytic region, a transmembrane region, and an extracellular region.
OR13A1 is a 13-kDa protein that is expressed in the olfactory system of the human body. It is a member of the superfamily of GPCRs, and it is characterized by the presence of a catalytic region, a transmembrane region, and an extracellular region. The catalytic region of OR13A1 contains a catalytic site that is involved in the regulation of various cellular processes. The transmembrane region of OR13A1 contains a putative intracellular signaling pathway that is involved in the regulation of various cellular processes. The extracellular region of OR13A1 contains a region that is involved in the regulation of the olfactory system.
OR13A1 has been shown to play a role in the regulation of various cellular processes, including the regulation of sensory perception and the regulation of neurotransmitter release. For example, studies have shown that OR13A1 is involved in the regulation of the release of neurotransmitters, such as serotonin and dopamine, from the olfactory neurons. OR13A1 has also been shown to play a role in the regulation of the growth and development of the olfactory system, as well as the regulation of inflammation.
Due to its involvement in the regulation of various cellular processes, OR13A1 has been considered as a potential drug target or biomarker. Researchers have been interested in the development of compounds that can selectively interact with OR13A1 and modulate its activity. This has led to the study of various compounds, including small molecules, peptides, and proteins, that have been shown to interact with OR13A1.
One of the most promising compounds that has been shown to interact with OR13A1 is called PW-1469. PW-1469 is a small molecule that is derived from a natural product, and it has been shown to block the activity of OR13A1 with high potency. PW-1469 has been shown to be effective in the treatment of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and anxiety disorders.
Another compound that has been shown to interact with OR13A1 is called R1-511. R1-511 is a peptide that is derived from the extracellular region of OR13A1 and it has been shown to block the activity of OR13A1 with high potency. R1-511 has been shown to be effective in the treatment of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and cancer.
In addition to these compounds, researchers have also been interested in studying the potential of proteins as drug targets or biomarkers. One of the most promising proteins that has been shown to interact with OR13A1 is called CRM1. CRM1 is a protein that is expressed in the olfactory system of the human body and it is a member of the superfamily of GPCRs. CRM1 has been shown to interact with OR13A1 and modulate its activity.
CRM1 has been shown to play a role in the regulation of various cellular processes, including the regulation of sensory perception and the regulation of neurotransmitter release. For example, studies have shown that CRM1 is involved in the regulation of the release of neurotransmitters, such as serotonin and dopamine, from the olfactory neurons. CRM1 has also been shown to play
Protein Name: Olfactory Receptor Family 13 Subfamily A Member 1
Functions: Odorant receptor
The "OR13A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR13A1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR13C2 | OR13C3 | OR13C4 | OR13C5 | OR13C8 | OR13C9 | OR13D1 | OR13F1 | OR13G1 | OR13H1 | OR13J1 | OR13Z2P | OR14A16 | OR14A2 | OR14C36 | OR14I1 | OR14J1 | OR14L1P | OR1A1 | OR1A2 | OR1B1 | OR1C1 | OR1D2 | OR1D4 | OR1D5 | OR1E1 | OR1E2 | OR1E3 | OR1F1 | OR1F2P | OR1G1 | OR1I1 | OR1J1 | OR1J2 | OR1J4 | OR1K1 | OR1L1 | OR1L3 | OR1L4 | OR1L6 | OR1L8 | OR1M1 | OR1N1 | OR1N2 | OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1 | OR2A1-AS1 | OR2A12 | OR2A14 | OR2A2 | OR2A20P | OR2A25 | OR2A4 | OR2A42 | OR2A7 | OR2A9P | OR2AE1 | OR2AG1 | OR2AG2 | OR2AJ1 | OR2AK2 | OR2AL1P | OR2AM1P | OR2AP1 | OR2AT4 | OR2B11 | OR2B2 | OR2B3 | OR2B6 | OR2C1 | OR2C3 | OR2D2 | OR2D3 | OR2F1 | OR2F2 | OR2G2 | OR2G3 | OR2G6 | OR2H1 | OR2H2 | OR2I1P | OR2J1 | OR2J2 | OR2J3 | OR2J4P | OR2K2 | OR2L13 | OR2L1P | OR2L2 | OR2L3 | OR2L5 | OR2L8 | OR2L9P | OR2M1P | OR2M2 | OR2M3 | OR2M4
